Arunava Bandyopadhaya
Project Lead & Senior Scientist - Research & Development , Immunology & Cell Based Therapy Project Astellas Pharma
Dr. Arunava Bandyopadhaya is a Project Lead in Immunology and Regenerative Medicine at Astellas Pharma, with over a decade of experience in translational immunology and drug discovery. Prior to joining Astellas, he was Lead Research Faculty at Harvard Medical School and Massachusetts General Hospital. His work focuses on advancing novel immunotherapies through biomarker-driven and mechanism-based approaches to address autoimmune and inflammatory diseases.
Seminars
Wednesday 1st April 2026
Looking Beyond the Mouse to Accelerate Preclinical & Translational Activities
4:15 pm
- Identify the limits of traditional murine models and where they fail to predict human trial outcomes
- Using advanced human-based models to capture the complexity and variability of patient responses, enabling more accurate therapeutic development
- Empower researchers with promising tools such as organoids, organ on chip, and patient-derived cells for human-relevant biology that streamline candidate selection, and support precision medicine approaches
